Meinian Health has released a blue book of tens of millions of physical examination data for four consecutive years.
Relying on 19.8 million adult desensitized physical examination samples across the country, Meinian Health has released a blue book of tens of millions of physical examination data for four consecutive years.
Quick Look
- On October 18, 2026, Meinian Health released the "Meinian Health 2025 Health Examination Big Data Blue Book" in Jinan.
- The report is based on 19.8 million adult physical examination samples across the country, revealing major national health risks such as nodules and metabolism, as well as regional and gender differences.
AI-generated summary
Why It Matters
Meinian Health has released tens of millions of national physical examination big data research results for four consecutive years. This report is compiled based on 19.8 million adult physical examination samples.
On October 18, 2026, the 2026 Epidemiology Academic Conference hosted by the Epidemiology Branch of the Chinese Society of Preventive Medicine was held in Jinan, Shandong. At the meeting, Meinian Health President Xu Tao officially released the "Meinian Health 2025 Health Examination Big Data Blue Book". The report was jointly compiled by Meinian Health Industry Holdings Co., Ltd., the Meinian Public Health Research Institute of Peking University School of Medicine, and the Health Management Branch of the China Health Promotion and Education Association. It relies on 19.8 million adult desensitization physical examination samples across the country, covering 554 physical examination centers in 31 provinces, autonomous regions, and municipalities directly under the Central Government. So far, Meinian Health has achieved regular and large-scale output of tens of millions of national physical examination big data research results for four consecutive years. With large-scale real physical examination samples and professional data analysis capabilities, Meinian Health has produced health research conclusions that are in line with the actual situation of the Chinese people, providing important data reference for public health management, public health scientific research and high-quality development of the industry.
Meinian Health has released a blue book of tens of millions of physical examination data for four consecutive years.
At the launch site, Meinian Health President Xu Tao said that in response to the national work deployment of "strengthening the prevention, treatment and management of multiple diseases to control the harm of chronic diseases", deeply mining the data value of massive real physical examination samples is an important way for preventive medicine institutions to implement the Healthy China strategy. This blue book is equivalent to an annual health portrait of tens of millions of workers. It is hoped that it can provide a reference for government departments, scientific research institutions and the general public, help promote the implementation of the "screening-diagnosis-management-health" integrated chronic disease health management model, and further enhance the health awareness of early screening and early intervention in the whole society.
This blue book is based on tens of millions of sample data analysis and shows that nodules and metabolic problems have become the two main health risk clusters for the current physical examination population. For the first time, the report lists central obesity measured by waist circumference as a key analysis indicator, reminding the public that judging obesity should not just look at weight values. Data show that half of the people undergoing physical examination are overweight or obese, and one-third of the people have central obesity. According to the "Expert Consensus on the Prevention and Control of Obesity in Chinese Residents" standards, the study defines central obesity as waist circumference ≥90cm for men and waist circumference ≥85cm for women.
There is a significant age inflection point for metabolic chronic diseases, and the risk of the "three highs" rises rapidly after the age of 40. Data show that nearly a quarter of the population has been diagnosed with high blood pressure, nearly 30% have dyslipidemia, and nearly one-tenth of the population has been diagnosed with diabetes. The overall detection rate of coronary artery calcification reached 15%, with the detection rate of 19.1% for men and 10.8% for women. The detection of calcified plaque plays an important warning role in the early prevention and treatment of coronary heart disease.
The national health status also shows obvious gender and regional differences. In terms of health risks, women need to focus on breast and cervical health. More than 10% of women have been diagnosed with HPV infection, and high-risk HPV accounts for more than 70% of infected people; more than 40% of women have been diagnosed with breast nodules. Men are more likely to face urinary-related health risks such as high uric acid and kidney stones.
From a regional perspective, the detection rate of hyperuricemia in males in Southwest Yunnan, Guizhou, Sichuan, Chongqing, Chongqing and Tibet exceeds 30%, which is significantly higher than the national overall detection rate of 15% and the average male level of 27%. The overall detection rate of kidney stones is 8.6%, with 11.3% for males and 5.7% for females. The detection rate of male kidney stones in central China's Henan, Hubei, and Hunan regions is as high as 18.3%, which once again reminds the importance of drinking enough water every day.
Comparing the tens of millions of physical examination data tracked continuously for four years, many national health risk indicators are on the rise: the detection rate of overweight or obesity increased from 49.7% to 52.3%; the detection rate of thyroid nodules increased from 40.3% to 49.5%; the detection rate of fatty liver increased from 40.1% to 44.3%; and the detection rate of female breast nodules increased from 31.5% to 40.2%. It is gratifying that the improvement of digestive health has shown results, and the Helicobacter pylori infection rate has continued to decline for four consecutive years, falling from 32.8% to 22.3%.
The blue book specifically reminds that the vast majority of lung nodules, thyroid nodules, and breast nodules belong to the low-risk category, with a low proportion of suspected malignancy. The public does not need to be overly anxious and panic, but should follow the doctor's instructions to complete stratification and regular follow-up reviews.
The report also summarized the regional and seasonal patterns of domestic health risks: high blood pressure, obesity, fatty liver and other metabolic abnormalities are "high in the north and low in the south"; high uric acid and kidney stones are "high in the south and low"; the detection rate of thyroid, breast and lung nodules is higher in the east than in the central and west. The risks of hypertension, carotid plaque, diabetes and other diseases continue to increase with age; blood pressure and fasting blood sugar also have seasonal fluctuation characteristics of "high in winter and low in summer".
Relying on the long-term accumulation of tens of millions of big data for four consecutive years, Meinian Health Blue Book has already surpassed the positioning of ordinary industry reports and built a communication bridge between the actual needs of public health and professional medical research. For ordinary people, the health patterns summarized based on four years of massive samples can help the public objectively understand the current high-incidence health problems, establish scientific health management concepts, and achieve pre-emptive disease prevention; for the big health industry, four consecutive years of tens of millions of data research, for academic exploration, technology iteration, and services The upgrade provides solid materials to promote the transformation of the physical examination industry from traditional screening to precision health management driven by big data; for the public health field, long-term and large-scale accumulation of national health data can provide strong support for disease prevention and control, health intervention system construction, and national health planning, and help implement the Healthy China strategy.
Xu Tao said that in the future, Meinian Health will continue to leverage the advantages of the preventive medicine big data platform, continue to deepen the collaboration between industry, academia and research, stably output annual epidemiological research results, promote the transformation of physical examination big data results into public health construction, chronic disease management, and health science education, continue to improve the health literacy of the whole people, and contribute to the construction of a healthy China.
Open Questions
- How can future interventions be targeted at specific health risks in different geographies?




